Company · CIK 0001728328 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
InMed Pharmaceuticals Inc. · INM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 PForm 4 → | Sep 16, 6:58 pm EDT | ADAR1 Capital Management, LLC +110% Owner | 91,101 | $1.30 | $118,076 | 892,101 | +11.4% | |
| Jul 15, 2026 PForm 4 → | Jul 17, 7:29 pm EDT | ADAR1 Capital Management, LLC +110% Owner | 1,000 | $1.56 | $1,555 | 801,000 | +0.13% | |
| Jul 14, 2026 PForm 4 → | Jul 16, 9:58 pm EDT | Vivo Opportunity, LLC +310% Owner | 20,546 | $1.55 | $31,846 | 75,019 | +37.7% | |
| Jun 30, 2026 PForm 4 → | Jul 2, 7:02 pm EDT | Vivo Opportunity, LLC +310% Owner | 6,551 | $1.55 | $10,148 | 73,135 | +9.84% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.